4-Oct-2024
PRNewswire (Wed, 2-Oct 7:00 AM ET)
What's Going On With Tilray Brands Stock Monday?
Benzinga (Mon, 30-Sep 12:27 PM ET)
Aurora CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors
PRNewswire (Fri, 20-Sep 7:00 AM ET)
PRNewswire (Tue, 17-Sep 7:00 AM ET)
Aurora Cannabis and Vectura Fertin Pharma, Inc. announce launch of novel Luo CBD lozenge
PRNewswire (Mon, 9-Sep 7:00 AM ET)
Aurora Cannabis Announces Results of 2024 Annual General and Special Meeting
PRNewswire (Mon, 12-Aug 7:00 AM ET)
Aurora Cannabis Announces Fiscal 2025 First Quarter Results and Delivers Positive Free Cash Flow
PRNewswire (Wed, 7-Aug 7:00 AM ET)
Aurora Cannabis and Vectura Fertin Pharma, Inc. announce commercial collaboration
PRNewswire (Thu, 1-Aug 7:00 AM ET)
PRNewswire (Tue, 30-Jul 7:00 AM ET)
Aurora Cannabis to Host First Quarter 2025 Investor Conference Call
PRNewswire (Mon, 29-Jul 7:00 AM ET)
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.
Aurora Cannabis - Common Shares trades on the NASDAQ stock market under the symbol ACB.
As of October 4, 2024, ACB stock price climbed to $5.50 with 573,878 million shares trading.
ACB has a beta of 1.63, meaning it tends to be more sensitive to market movements. ACB has a correlation of 0.06 to the broad based SPY ETF.
ACB has a market cap of $300.63 million. This is considered a Small Cap stock.
Last quarter Aurora Cannabis - Common Shares reported $61 million in Revenue and $.09 earnings per share. This beat revenue expectation by $4 million and exceeded earnings estimates by $.44.
In the last 3 years, ACB traded as high as $86.90 and as low as $2.84.
The top ETF exchange traded funds that ACB belongs to (by Net Assets): MJ, GWX, SFYF, DXIV.
ACB has underperformed the market in the last year with a price return of -0.5% while the SPY ETF gained +36.6%. However, in the short term, ACB had mixed performance relative to the market. It has outperformed in the last 3 months, returning +12.2% vs +4.2% return in SPY. But in the last 2 weeks, ACB shares have been beat by the market, returning -3.8% compared to an SPY return of +0.8%.
ACB support price is $5.30 and resistance is $5.68 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACB shares will trade within this expected range on the day.